The inventors of medical devices struggle to win approval for their gadgets, as federal regulators follow a first-do-no-harm strategy after recent drug and medical-device scandals. That makes it harder for innovators to find money to develop ideas, industry-watchers say. "What it essentially boils down to is that uncertainty strangles innovation," says Jessica Canning, Dow Jones VentureSource research chief.

Full Story:

Related Summaries